ATLANTICUS HOLDINGS CORPORATION

ATLC

CIK 0001464343 · Quarterly mode · latest period FY2025 (Q4) (ending 2025-12-31) · sourced from SEC EDGAR

At a glance · FY2025 (Q4)

Revenue
$734M
↑+107.8% +$381Mvs FY2024 (Q4)
Operating Income
$677M
↑+114.0% +$361Mvs FY2024 (Q4)
Net Income
$35M
↑+12.2% +$4Mvs FY2024 (Q4)
Gross Profit
$679M
↑+113.7% +$361Mvs FY2024 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Poor
19/100
  • Profitability
    0Insufficient data
  • Liquidity
    0Insufficient data
  • Leverage
    0Insufficient data
  • Efficiency
    12Asset Turnover 0.36x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +107.8% (10% = solid, 25%+ = elite)
  • Margin Trend
    0Insufficient data

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project ATLC's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

22%

Trailing 3-yr CAGR was 22.4%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$992.45
Total enterprise IV
$19.03B
Diluted shares
0.02B
Terminal PV
$14.63B (77% of total)
Year-5 FCF
$1.72B
YearProjected FCFDiscounted PV
+1$778M$708M
+2$950M$785M
+3$1.16B$870M
+4$1.41B$965M
+5$1.72B$1.07B
Terminal$23.56B$14.63B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
investment in PP&E
Stock buybacks (TTM)
$70M
share count reduction
Stock-based comp (TTM)
$4M
non-cash dilution

Balance sheet · 2025-12-31

latest filed snapshot
Total assets
$7.62B
everything owned
Total liabilities
$6.98B
everything owed
Stockholders' equity
$609M
shareholder claim

Recent performance · 63 quarters

Revenue↑+107.8% +$381M
$734M
Net Income↑+12.2% +$4M
$35M
Free Cash Flow↑+117.2% +$144M
$266M

Drill down